ARC 5837C
PHARMACY BOARD[657]
Notice of Intended Action
Proposing rule making related to controlled substances and precursor substances and providing an opportunity for public comment
The Board of Pharmacy hereby proposes to amend Chapter 10, “Controlled Substances,” and Chapter 12, “Precursor Substances,” Iowa Administrative Code.
Legal Authority for Rule Making
This rule making is proposed under the authority provided in Iowa Code sections 124.201 and 124B.2(2).
State or Federal Law Implemented
This rule making implements, in whole or in part, Iowa Code sections 124.201 and 124B.2(2).
Purpose and Summary
The proposed amendments temporarily identify three List I chemicals (used in the illicit manufacture of MDMA/“ecstasy”-type substances and amphetamine/methamphetamine) as precursor substances and add the following four substances into the Iowa Controlled Substances Act, both actions in response to similar scheduling action by the federal Drug Enforcement Administration:
	●	Two hallucinogenic substances into Schedule I,
	●	One FDA-approved ADHD medication into Schedule IV, and
	●	One FDA-approved migraine medication into Schedule V.
Fiscal Impact
This rule making has no fiscal impact to the State of Iowa.
Jobs Impact
After analysis and review of this rule making, no impact on jobs has been found.
Waivers
Any person who believes that the application of the discretionary provisions of this rule making would result in hardship or injustice to that person may petition the Board for a waiver of the discretionary provisions, if any, pursuant to 657—Chapter 34.
Public Comment
Any interested person may submit written comments concerning this proposed rule making. Written comments in response to this rule making must be received by the Board no later than 4:30 p.m.	on August 31, 2021. Comments should be directed to:

Sue Mears
Board of Pharmacy
400 S.W. 8th Street, Suite E
Des Moines, Iowa 50309
Email: sue.mears@iowa.gov	
Public Hearing
No public hearing is scheduled at this time. As provided in Iowa Code section 17A.4(1)“b,” an oral presentation regarding this rule making may be demanded by 25 interested persons, a governmental subdivision, the Administrative Rules Review Committee, an agency, or an association having 25 or more members.
Review by Administrative Rules Review Committee
The Administrative Rules Review Committee, a bipartisan legislative committee which oversees rule making by executive branch agencies, may, on its own motion or on written request by any individual or group, review this rule making at its regular monthly meeting or at a special meeting. The Committee’s meetings are open to the public, and interested persons may be heard as provided in Iowa Code section 17A.8(6).
The following rule-making actions are proposed:
	Item 1. Adopt the following new subrule 10.39(7):
	10.39(7) Amend Iowa Code section 124.210(6) by adding the following new paragraph:
	n. 	Serdexmethylphenidate.
	Item 2. Adopt the following new subrule 10.39(8):
	10.39(8) Amend Iowa Code section 124.212(5) by adding the following new paragraph:
	f. 	Lasmiditan [2,4,6-trifluoro-N-(6-(1-methylpiperidine-4-carbonyl)pyridine-2-yl-benzamide].
	Item 3. Adopt the following new subrule 10.39(9):
	10.39(9) Amend Iowa Code section 124.204(4) by adding the following new paragraphs:
	av. 	methyl 2-(1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate. Other names: 4F-MDMB-BINACA, 4F-MDMB-BUTINACA.
	aw. 	1-(4-methyoxyphenyl)-N-methylpropan-2-amine. Other names: para-methoxymethamphetamine, PMMA.
	Item 4. Rescind subrule 12.1(1) and adopt the following new subrule in lieu thereof:
	12.1(1) Amend Iowa Code section 124B.2(1) by adding the following new paragraphs:
	ae. 	3,4-MDP-2-P methyl glycidate (PMK glycidate) and its optical and geometric isomers.
	af. 	3,4-MDP-2-P methyl glicidic acid (PMK glycidic acid) and its salts, optical and geometric isomers, and salts of isomers.
	ag. 	Alpha-phylacetoacetamide (APAA) and its optical isomers.